Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-19

Clinical Trial Update: Safety and Efficacy Assessments of Osalmid in Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

Early-phase clinical trial update evaluating safety and efficacy of Osalmid in patients with Multiple Myeloma (Phase 1/2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Osalmid

Snippet

Sponsor: Shanghai 10th People's Hospital | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN